Epidemiological evidence suggests that the secretion of TNF-α by activated microglia in patients is associated with an elevated risk of developing PD [231], while anti-TNF therapy has been linked to a significant reduction in PD incidence and promotes the survival of dopaminergic neurons [232, 233]. The gene discussed is TNF; the disease is Parkinson disease.